← back to search

Mehrdad Alemozaffar

Emory University Hospital ·
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Renal cell carcinoma treatment, Prostate Cancer Treatment and Research, and Prostate Cancer Diagnosis and Treatment.
h-index
25
citations
4,265
works
143
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial
The Journal of Urology 2024cited by 72position: middledoi
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy
Journal of Clinical Oncology 2023cited by 100position: middledoi
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis
Cancers 2023cited by 10position: middledoi
CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
Immunity 2022cited by 326position: middledoi
SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma.
Journal of Clinical Oncology 2021cited by 33position: middledoi
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
The Lancet Oncology 2020cited by 431position: middledoi
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Nature 2019cited by 830position: middledoi
Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation
American Journal of Clinical Oncology 2018cited by 62position: middledoi
Bladder cancer
Nature Reviews Disease Primers 2017cited by 816position: middledoi
Patient Frailty and Discharge Disposition Following Radical Cystectomy
Clinical Genitourinary Cancer 2017cited by 57position: middledoi
The role of adjuvant radiotherapy in pathologically lymph node‐positive prostate cancer
Cancer 2016cited by 62position: middledoi
Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
Urology 2016cited by 50position: middledoi
Urologist Use of Cystoscopy for Patients Presenting With Hematuria in the United States
Urology 2016cited by 40position: middledoi
C-reactive protein in urologic cancers
Molecular Aspects of Medicine 2015cited by 34position: middledoi
Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy
Asian journal of urology 2015cited by 25position: middledoi
Benchmarks for Operative Outcomes of Robotic and Open Radical Prostatectomy: Results from the Health Professionals Follow-up Study
European Urology 2014cited by 102position: firstdoi
Technical Refinement and Learning Curve for Attenuating Neurapraxia During Robotic-Assisted Radical Prostatectomy to Improve Sexual Function
European Urology 2012cited by 67position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Viraj A. Master · Emory University8 papers (2015–2022)Dattatraya Patil · Emory University5 papers (2015–2023)Kenneth Ogan · Emory University4 papers (2015–2017)Ömer Küçük · Emory University3 papers (2015–2018)Christopher P. Filson · Emory Healthcare3 papers (2016–2018)Peter T. Nieh · Emory University3 papers (2015–2018)Yoram Baum · Emory University3 papers (2015–2016)Martin G. Sanda · Emory University3 papers (2014–2023)Alan So · Queen's University2 papers (2021–2023)N. Jegadeesh · John H. Stroger, Jr. Hospital of Cook County2 papers (2016–2018)Timothy A. Masterson · Indiana University School of Medicine2 papers (2021–2023)Clint Cary · Indiana University School of Medicine2 papers (2021–2023)Timothy C. Brand · Houston Methodist2 papers (2021–2023)Richard J. Cassidy · Florida Cancer Specialists & Research Institute2 papers (2016–2018)Phillip M. Pierorazio · University of Pennsylvania Press2 papers (2021–2023)Jonathan Huang · Tufts University2 papers (2015–2015)Siamak Daneshmand · The University of Texas at San Antonio2 papers (2021–2023)Craig R. Nichols · Uniformed Services University of the Health Sciences2 papers (2021–2023)Mehmet Asım Bilen · Emory Healthcare2 papers (2018–2022)Peter C. Black · Prevention of Organ Failure2 papers (2021–2023)